These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: A novel AF9 breakpoint in MLL-AF9-positive acute monoblastic leukemia.
    Author: Alonso CN, Longo PL, Gallego MS, Medina A, Felice MS.
    Journal: Pediatr Blood Cancer; 2008 Apr; 50(4):869-71. PubMed ID: 18000862.
    Abstract:
    MLL-AF9 is the most frequent MLL rearrangement in childhood acute myeloid leukemia (AML) and it may be also found in acute lymphoblastic leukemia (ALL) of patients younger than 1-year-old (infants). We report a novel AF9 breakpoint site, located between previously reported sites A and B, detected in an infant who was diagnosed with AML-FAB M5. The occurrence of this new breakpoint should be considered when designing RT-PCR assays for the screening of MLL abnormalities. The precise characterization of the MLL-AF9 transcript is important to carry out the minimal residual disease analysis during the follow-up of the patients.
    [Abstract] [Full Text] [Related] [New Search]